{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:21:11Z","timestamp":1776187271785,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[1988,6,1]]},"DOI":"10.1136\/hrt.59.6.696","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:46:00Z","timestamp":1190151960000},"page":"696-705","source":"Crossref","is-referenced-by-count":17,"title":["Prediction of favourable responses to long term vasodilator treatment of pulmonary hypertension by short term administration of epoprostenol (prostacyclin) or nifedipine."],"prefix":"10.1136","volume":"59","author":[{"given":"A","family":"Rozkovec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J R","family":"Stradling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"MacDermot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C M","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C T","family":"Dollery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.65.4.645","article-title":"The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause","volume":"65","author":"Lupi-Herrera, E.; Sandoval, J.; Seoane, M.; Bialostozky, D.","year":"1982","unstructured":"Lupi-Herrera E, Sandoval J, Seoane M, Bialostozky D. The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause. Circulation 1982;65:645-50.","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/hrt.50.6.579","article-title":"Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension","volume":"50","author":"McGoon, M.D.; Seward, J.B.; Vlietstra, R.E.; Choo, M.H.; Moyer, T.P.; Reeder, G.S.","year":"1983","unstructured":"McGoon MD, Seward JB, Vlietstra RE, Choo MH, Moyer TP, Reeder GS. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension. Br Heart J 1983;50:579-85.","journal-title":"Br Heart J"},{"issue":"1","key":"ref_3","first-page":"191","article-title":"The effect of vasodilator therapy on the clinical outcome ofpatients with primary pulmonary hypertension","volume":"71","author":"Rich, S.; Brundage, B.H.; Levy, P.S.","year":"1985","unstructured":"Rich S, Brundage BH, Levy PS. The effect of vasodilator therapy on the clinical outcome ofpatients with primary pulmonary hypertension. Circulation 1985;71:1 191-6.","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/0002-9149(83)90210-2","article-title":"Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hyptertension: a combined radionuclide-hemodynamic study","volume":"51","author":"Brent, B.N.; Berger, H.J.; Matthay, R.A.; Mahler, D.; Pytlik, L.; Zaret, B.L.","year":"1983","unstructured":"Brent BN, Berger HJ, Matthay RA, Mahler D, Pytlik L, Zaret BL. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hyptertension: a combined radionuclide-hemodynamic study. Am J Cardiol 1983;51:1682-9.","journal-title":"Am J Cardiol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0735-1097(84)80048-0","article-title":"Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease","volume":"4","author":"Packer, M.; Medina, N.; Yushak, M.","year":"1984","unstructured":"Packer M, Medina N, Yushak M. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease. J Am Coll Cardiol 1984;4:890-901.","journal-title":"J Am Coll Cardiol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-8703(85)90013-4","article-title":"A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension","volume":"110","author":"Groves, B.M.; Rubin, L.J.; Frosolono, M.F.; Cato, A.E.; Reeves, J.T.","year":"1985","unstructured":"Groves BM, Rubin LJ, Frosolono MF, Cato AE, Reeves JT. A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension. Am Heart J 1985;110: 1200-4.","journal-title":"Am Heart J"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-60-4-611","article-title":"The pathophysiology of scleroderma involving the heart and respiratory system","volume":"60","author":"Sackner, M.A.; Akgun, N.; Kimbel, P.; Lewis, D.H.","year":"1964","unstructured":"Sackner MA, Akgun N, Kimbel P, Lewis DH. The pathophysiology of scleroderma involving the heart and respiratory system. Ann Intern Med 1964;60: 611-30.","journal-title":"Ann Intern Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2214\/ajr.144.1.27","article-title":"Perfusion lung scanning: differentiation of primary from thromboembolic pulmonary hypertension","volume":"144","author":"Lisbona, R.; Kreisman, H.; Novales-Diaz, J.; Derbekyan, V.","year":"1985","unstructured":"Lisbona R, Kreisman H, Novales-Diaz J, Derbekyan V. Perfusion lung scanning: differentiation of primary from thromboembolic pulmonary hypertension. Am J Roentgenol 1985;144:27-30.","journal-title":"Am J Roentgenol"},{"key":"ref_9","first-page":"397","article-title":"Intrathoracic pressure variations and pulmonary artery pressure in patients with chronic obstructive lung disease","volume":"15","author":"Zielinski, J.","year":"1979","unstructured":"Zielinski J. Intrathoracic pressure variations and pulmonary artery pressure in patients with chronic obstructive lung disease. Bull Eur Physiopathol Respir 1979;15:397-405.","journal-title":"Bull Eur Physiopathol Respir"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/0002-9149(85)90412-6","article-title":"Circulatory effects of coffee in relation to the pharmacokinetics of caffeine","volume":"56","author":"Smits, P.; Thien, T.; van't Lear, A.","year":"1985","unstructured":"Smits P, Thien T, van't Lear A. Circulatory effects of coffee in relation to the pharmacokinetics of caffeine. Am J Cardiol 1985;56:958-63.","journal-title":"Am J Cardiol"},{"key":"ref_11","article-title":"Clinical exercise testing","author":"Jones, N.L.; Campbell, E.J.M.","year":"1982","unstructured":"Jones NL, Campbell EJM. Clinical exercise testing. 2nd ed. Philadelphia: W B Saunders, 1982.","edition":"2nd ed"},{"key":"ref_12","first-page":"791","article-title":"The accuracy of the Hewlett-Packard 47201A ear oximeter below 50% saturation","volume":"18","author":"Stradling, JR","year":"1982","unstructured":"Stradling JR. The accuracy of the Hewlett-Packard 47201A ear oximeter below 50% saturation. Bull Eur Physiopathol Respir 1982;18:791-4.","journal-title":"Bull Eur Physiopathol Respir"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/hrt.15.1.47","article-title":"The mechanism of effort syncope in primary pulmonary hypertension and cyanotic congenital heart disease","volume":"15","author":"Howarth, S.; Lowe, J.B.","year":"1953","unstructured":"Howarth S, Lowe JB. The mechanism of effort syncope in primary pulmonary hypertension and cyanotic congenital heart disease. Br Heart J 1953;15:47-54.","journal-title":"Br Heart J"},{"key":"ref_14","first-page":"1237","article-title":"Vascular reactivity and pulmonary hypertension in systemic sclerosis","volume":"26","author":"Rozkovec, A.; Bernstein, R.; Asherson, R.A.; Oakley, C.M.","year":"1983","unstructured":"Rozkovec A, Bernstein R, Asherson RA, Oakley CM. Vascular reactivity and pulmonary hypertension in systemic sclerosis. Arthritis Rheum 1983;26:1237-40.","journal-title":"Arthritis Rheum"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.65.4.645","article-title":"The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause","volume":"65","author":"Lupi-Herrera, E.; Sandoval, J.; Seoane, M.; Bialostozky, D.","year":"1982","unstructured":"Lupi-Herrera E, Sandoval J, Seoane M, Bialostozky D. The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause. Circulation 1982;65:645-50.","journal-title":"Circulation"},{"issue":"5","key":"ref_16","first-page":"119","article-title":"Reassessment of the effects of vasodilator drugs in primary pulmonary hyptertension: guidelines for determining a pulmonary vasodilator response","volume":"1","author":"Rich, S.; Martinez, J.; Lam, W.; Levy, P.S.; Rosen, K.M.","year":"1983","unstructured":"Rich S, Martinez J, Lam W, Levy PS, Rosen KM. Reassessment of the effects of vasodilator drugs in primary pulmonary hyptertension: guidelines for determining a pulmonary vasodilator response. Am Heart J 1983;1O5:119-27.","journal-title":"Am Heart J"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/01.CIR.66.2.334","article-title":"Prostacylin-induced acute pulmonary vasodilation in primary pulmonary hypertension","volume":"66","author":"Rubin, L.J.; Groves, M.B.; Reeves, J.T.; Frosolono, M.; Handel, F.; Cato, A.E.","year":"1982","unstructured":"Rubin LJ, Groves MB, Reeves JT, Frosolono M, Handel F, Cato AE. Prostacylin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation 1982;66:334-8.","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-99-4-433","article-title":"Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation","volume":"99","author":"Rubin, L.J.; Nicod, P.; Hillis, L.D.; Firth, B.G.","year":"1983","unstructured":"Rubin LJ, Nicod P, Hillis LD, Firth BG. Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation. Ann Intern Med 1983;99:433-8.","journal-title":"Ann Intern Med"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM198001103020201","article-title":"Oral hydralazine therapy for primary pulmonary hyptertension","volume":"302","author":"Rubin, L.J.; Peter, R.H.","year":"1980","unstructured":"Rubin LJ, Peter RH. Oral hydralazine therapy for primary pulmonary hyptertension. N Engl J Med 1980;302:69-73.","journal-title":"N Engl J Med"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/cvr\/4.1.23","article-title":"The estimation of oxygen consumption","volume":"4","author":"LaFarge, C.G.; Miettinen, O.S.","year":"1970","unstructured":"LaFarge CG, Miettinen OS. The estimation of oxygen consumption. Cardiovasc Res 1970;4:23-30.","journal-title":"Cardiovasc Res"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/jappl.1981.51.3.607","article-title":"Pulmonary vascular tone improves VA\/Q matching in obliterative pulmonary hypertension","volume":"51","author":"Dantzker, D.R.; Bower, J.S.","year":"1981","unstructured":"Dantzker DR, Bower JS. Pulmonary vascular tone improves VA\/Q matching in obliterative pulmonary hypertension. J Appl Physiol 1981;51:607-13.","journal-title":"J Appl Physiol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJM198106253042606","article-title":"Inhibition of hypoxic pulmonary vasoconstriction by nifedipine","volume":"304","author":"Simmonneau, G.; Esourrou, P.; Duroux, P.; Lockhart, A.","year":"1981","unstructured":"Simmonneau G, Esourrou P, Duroux P, Lockhart A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med 1981;304:1582-5.","journal-title":"N Engl J Med"},{"key":"ref_23","first-page":"544","article-title":"Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled doubleblind study","volume":"129","author":"Kennedy, T.P.; Michael, JR, Huang; C.-K.","year":"1984","unstructured":"Kennedy TP, Michael JR, Huang C-K, et al. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled doubleblind study. Am Rev Respir Dis 1984;129:544-51.","journal-title":"Am Rev Respir Dis"},{"key":"ref_24","first-page":"102","article-title":"The effect of isoproterenol on the development and recovery of hypoxic pulmonary hypertension. A structural and hemodynamic study","volume":"121","author":"Fried, R.; Reid, L.M.","year":"1985","unstructured":"Fried R, Reid LM. The effect of isoproterenol on the development and recovery of hypoxic pulmonary hypertension. A structural and hemodynamic study. Am JPathol 1985;121:102-11.","journal-title":"Am JPathol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00005344-198303000-00025","article-title":"Effects of nifedipine on contractile responses to potassium, histamine, and 5-hydroxytryptamine in isolated human pulmonary vessels","volume":"5","year":"1983","unstructured":"Mikkelsen EO, Sakr AMR, Jespersen LT. Effects of nifedipine on contractile responses to potassium, histamine, and 5-hydroxytryptamine in isolated human pulmonary vessels. J Cardiovasc Pharmacol 1983;5:317-20.","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref_26","first-page":"342","article-title":"The case for treatment of selected patients with primary pulmonary hypertension","volume":"134","author":"Reeves, J.T.; Groves, B.M.; Turkevich, D.","year":"1986","unstructured":"Reeves JT, Groves BM, Turkevich D. The case for treatment of selected patients with primary pulmonary hypertension. Am Rev Respir Dis 1986;134:342-6.","journal-title":"Am Rev Respir Dis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/hrt.55.5.449","article-title":"Factors that influence the outcome of primary pulmonary hypertension","volume":"55","author":"Rozkovec, A.; Montanes, P.; Oakley, C.M.","year":"1986","unstructured":"Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J 1986;55:449-58.","journal-title":"Br Heart J"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/01.CIR.35.6.1028","article-title":"Effect of flow and pressure on pulmonary vessels. A semiquantitative study based on lung biopsies","volume":"35","author":"Wagenvoort, C.A.; Nauta, J.; van der Schaar, P.J.; Weeda, H.W.H.; Wagenvoort, N.","year":"1967","unstructured":"Wagenvoort CA, Nauta J, van der Schaar PJ, Weeda HWH, Wagenvoort N. Effect of flow and pressure on pulmonary vessels. A semiquantitative study based on lung biopsies. Circulation 1967; 35:1028-37.","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/hrt.57.3.270","article-title":"Treatment of primary pulmonary hypertension with intravenous epoprostenol (prostacyclin)","volume":"57","author":"Jones, D.K.; Higenbottam, T.W.; Wallwork, J.","year":"1987","unstructured":"Jones DK, Higenbottam TW, Wallwork J. Treatment of primary pulmonary hypertension with intravenous epoprostenol (prostacyclin). Br Heart J 1987;57: 270-8.","journal-title":"Br Heart J"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.76.1.135","article-title":"High-dose calcium channelblocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy","volume":"76","author":"Rich, S.; Brundage, B.H.","year":"1987","unstructured":"Rich S, Brundage BH. High-dose calcium channelblocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 1987;76:135-41.","journal-title":"Circulation"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.59.6.696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:03:43Z","timestamp":1601082223000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.59.6.696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,6,1]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1988,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/hrt.59.6.696","relation":{},"ISSN":["1355-6037"],"issn-type":[{"value":"1355-6037","type":"print"}],"subject":[],"published":{"date-parts":[[1988,6,1]]}}}